Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
Pandikannan Krishnamoorthy, Athira S. Raj, Swagnik Roy, et al.
Computers in Biology and Medicine (2020) Vol. 128, pp. 104123-104123
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
SARS-CoV-2 activates ER stress and Unfolded protein response
Lívia Rosa-Fernandes, Lucas C. Lázari, Janaína Macedo da Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 32
SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis
Asmaa Samy, Mohamed A. Maher, Nehal Adel Abdelsalam, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Multistaged In Silico Discovery of the Best SARS-CoV-2 Main Protease Inhibitors amongst 3009 Clinical and FDA-Approved Compounds
Ibrahim H. Eissa, Abdulrahman M. Saleh, Sara T. Al‐Rashood, et al.
Journal of Chemistry (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 4
Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
Sara Chiappalupi, Laura Salvadori, Rosario Donato, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 876-876
Open Access | Times Cited: 30
Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19
Qiying Jin, Wanxi Li, Wendi Yu, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106134-106134
Open Access | Times Cited: 14
Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm
Yuri Yépez, Mariana Marcano-Ruiz, Rafael dos Santos Bezerra, et al.
Genetics and Molecular Biology (2022) Vol. 45, Iss. 1
Open Access | Times Cited: 10
Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities
Nimisha Ghosh, Indrajit Saha, Nikhil Sharma
Computers in Biology and Medicine (2021) Vol. 138, pp. 104889-104889
Open Access | Times Cited: 13
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics
Madison T. Gray, Israel Guerrero‐Arguero, Antonio Solis‐Leal, et al.
PeerJ (2022) Vol. 10, pp. e13090-e13090
Open Access | Times Cited: 9
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
Srividhya Venkataraman
Vaccines (2022) Vol. 10, Iss. 11, pp. 1805-1805
Open Access | Times Cited: 9
Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses
Qian-Chun Gong, Ren-Di Jiang, Lina Ji, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data
Ying Wang, Yangguang Su, Kairui Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34244-e34244
Open Access | Times Cited: 1
Machine learning‐driven blood transcriptome‐based discovery of SARS‐CoV‐2 specific severity biomarkers
Pandikannan Krishnamoorthy, Athira S. Raj, Himanshu Kumar
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 4
Protein Arginylation Is Regulated during SARS-CoV-2 Infection
Janaína Macedo-da-Silva, Lívia Rosa-Fernandes, Vinícius M. Gomes, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 290-290
Open Access | Times Cited: 4
Evolutionary selectivity of amino acid is inspired from the enhanced structural stability and flexibility of the folded protein
S.J. Aditya Rao, Nandini P. Shetty
Life Sciences (2021) Vol. 281, pp. 119774-119774
Closed Access | Times Cited: 10
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection
Cristian Arriaga-Canon, Laura Contreras-Espinosa, Rosa Rebollar‐Vega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11058-11058
Open Access | Times Cited: 5
HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach
Bradley Ward, Jean Cyr Yombi, Jean‐Luc Balligand, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1373-1373
Open Access | Times Cited: 4
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 87-87
Open Access | Times Cited: 5
The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes
Tilak Nayak, Debjit De, Pradeep K. Dhal
Infection Genetics and Evolution (2021) Vol. 92, pp. 104892-104892
Open Access | Times Cited: 5
Comparative transcriptome reveals EphA2 and c-Fos as key factors driving enhanced replication in high-passage porcine deltacoronavirus strain
Shiyu Liu, Qi Peng, Baochao Fan, et al.
Veterinary Microbiology (2024) Vol. 297, pp. 110211-110211
Closed Access
Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation
Huy Quang Quach, Krista M. Goergen, Diane E. Grill, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
Yuzhuang Liu, Tianyi Lu, Cuidan Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
In silico transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss
Pezhman Salehi, Marisa Zallocchi, Sarath Vijayakumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Differing coronavirus genres alter shared host signaling pathways upon viral infection
Diana Cruz-Pulido, Wilberforce Zachary Ouma, Scott P. Kenney
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
SARS-Coronavirus 2, A Metabolic Reprogrammer: A Review in the Context of the Possible Therapeutic Strategies
Mohanan Valiya Veettil, Praveen Kumar Gopi, T.R. Anju, et al.
Current Drug Targets (2021) Vol. 23, Iss. 8, pp. 770-781
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top